Cargando…

Screening a protein kinase inhibitor library against Plasmodium falciparum

BACKGROUND: Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malaria is sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallyburton, Irene, Grimaldi, Raffaella, Woodland, Andrew, Baragaña, Beatriz, Luksch, Torsten, Spinks, Daniel, James, Daniel, Leroy, Didier, Waterson, David, Fairlamb, Alan H., Wyatt, Paul G., Gilbert, Ian H., Frearson, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678585/ https://www.ncbi.nlm.nih.gov/pubmed/29115999 http://dx.doi.org/10.1186/s12936-017-2085-4

Ejemplares similares

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011)

Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library
por: Woodland, Andrew, et al.
Publicado: (2015)

From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules
por: Woodland, Andrew, et al.
Publicado: (2013)

The Design and Synthesis of Potent and Selective Inhibitors of Trypanosoma brucei Glycogen Synthase Kinase 3 for the Treatment of Human African Trypanosomiasis
por: Urich, Robert, et al.
Publicado: (2014)

Toolkit of Approaches To Support Target-Focused Drug Discovery for Plasmodium falciparum Lysyl tRNA Synthetase
por: Milne, Rachel, et al.
Publicado: (2022)

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)

Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015)

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
por: Spinks, Daniel, et al.
Publicado: (2012)

Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
por: Baragaña, Beatriz, et al.
Publicado: (2016)

Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
por: Hewitt, Stephen Nakazawa, et al.
Publicado: (2016)

Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum
por: Avery, Vicky M, et al.
Publicado: (2014)

Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009)

Chemical Validation of Trypanothione Synthetase: A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
por: Torrie, Leah S., et al.
Publicado: (2009)

Quinol derivatives as potential trypanocidal agents
por: Capes, Amy, et al.
Publicado: (2012)

IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening
por: Tidten-Luksch, Naomi, et al.
Publicado: (2012)

Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3
por: Cleghorn, Laura A T, et al.
Publicado: (2011)

Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
por: Brenk, Ruth, et al.
Publicado: (2008)

Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
por: Norcross, Neil R., et al.
Publicado: (2016)

Substituted Aminoacetamides as Novel Leads for Malaria Treatment
por: Norcross, Neil R., et al.
Publicado: (2019)

Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1
por: Spinks, Daniel, et al.
Publicado: (2011)

One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
por: Mpamhanga, Chidochangu P., et al.
Publicado: (2009)

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011)

Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum
por: Le Manach, Claire, et al.
Publicado: (2013)

Validation of Plasmodium falciparum dUTPase as the target of 5′-tritylated deoxyuridine analogues with anti-malarial activity
por: Pérez-Moreno, Guiomar, et al.
Publicado: (2019)

A library of functional recombinant Plasmodium falciparum merozoite surface proteins
por: Crosnier, Cecile, et al.
Publicado: (2010)

Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static–Cidal Screening of Analogues
por: Cleghorn, Laura A. T., et al.
Publicado: (2023)

Comparison and Optimization of Different Methods for the In Vitro Production of Plasmodium falciparum Gametocytes
por: Roncalés, María, et al.
Publicado: (2012)

Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase
por: Patterson, Stephen, et al.
Publicado: (2009)

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
por: Peatey, Christopher L, et al.
Publicado: (2012)

Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model
por: Tipsuwan, Wachiraporn, et al.
Publicado: (2011)

Construction and use of Plasmodium falciparum phage display libraries to identify host parasite interactions
por: Lauterbach, Sonja B, et al.
Publicado: (2003)

Pfkelch13 Plasmodium falciparum Mutations in Huambo, Angola
por: Rodrigues, Ana Beatriz Batista, et al.
Publicado: (2022)

Nuclear DBF-2-related Kinases Are Essential Regulators of Cytokinesis in Bloodstream Stage Trypanosoma brucei
por: Ma, Jiangtao, et al.
Publicado: (2010)

Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
por: van Schalkwyk, Donelly A., et al.
Publicado: (2019)

Combating multidrug‐resistant Plasmodium falciparum malaria
por: Thu, Aung Myint, et al.
Publicado: (2017)

Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library
por: Zenonos, Zenon A, et al.
Publicado: (2014)

Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
por: Patterson, Stephen, et al.
Publicado: (2011)

Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates
por: Nardella, Flore, et al.
Publicado: (2021)

Recent Molecular Assessment of Plasmodium vivax and Plasmodium falciparum Asymptomatic Infections in Botswana
por: Motshoge, Thato, et al.
Publicado: (2021)

Isoxazolopyrimidine-Based Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity
por: Kokkonda, Sreekanth, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c7gi4hech6up2ip7uhqof8obe8